Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 3
2008 3
2009 1
2010 1
2012 2
2013 3
2014 2
2015 4
2016 1
2017 3
2018 2
2019 1
2021 1
2022 1
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis - a review of population-specific evidence from randomized clinical trials.
Bayas A, Christ M, Faissner S, Klehmet J, Pul R, Skripuletz T, Meuth SG. Bayas A, et al. Among authors: klehmet j. Ther Adv Neurol Disord. 2023 Jan 24;16:17562864221146836. doi: 10.1177/17562864221146836. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 36710720 Free PMC article. Review.
[Public health situation of CIDP patients in nine German centers-neuritis network Germany].
Fisse AL, Motte J, Grüter T, Kohle F, Kronlage C, Stahl JH, Winter N, Seeliger T, Gingele S, Stascheit F, Hotter B, Klehmet J, Kummer K, Enax-Krumova EK, Sturm D, Skripuletz T, Schmidt J, Yoon MS, Pitarokoili K, Lehmann HC, Grimm A; Mitglieder des Neuritis Netz. Fisse AL, et al. Among authors: klehmet j. Nervenarzt. 2023 Apr;94(4):320-326. doi: 10.1007/s00115-022-01377-0. Epub 2022 Aug 23. Nervenarzt. 2023. PMID: 35997784 Free PMC article. German.
Pregnancy outcomes in female multiple sclerosis patients exposed to intramuscular interferon beta-1a or peginterferon beta-1a reported in a German Patient Support Programme - results from the non-interventional post-authorization safety study PRIMA.
Klehmet J, Begus-Nahrmann Y, Taipale K, Niemczyk G, Rehberg-Weber K. Klehmet J, et al. Ther Adv Neurol Disord. 2023 Dec 15;16:17562864231214041. doi: 10.1177/17562864231214041. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 38107443 Free PMC article.
30 results